Story
Jill was diagnosed with Amyloidosis in March 2022 after months of many probing tests, by the time she was eventually diagnosed her kidneys were damaged beyond repair. Then started the chemotherapy and dialysis journey, the chemotherapy was brutal. Jill succumbed to a dialysis complication and left us on the 3rd February 2023. She never complained about her lot and always remained positive throughout. Amyloidosis is a rare disease caused by damaging build up of abnormal protein fibres, called amyloid, within the tissues and organs. Amyloidosis can affect any part of the body and lead to life threatening organ failure. It causes the death of about one person in every thousand and there are about 6,000 cases in the UK at any time. Donations to the Amyloidosis Research Fund within the Royal Free Charity supports the research, development and patients of the UK NHS National Amyloidosis Centre (NAC) at the Royal Free Hospital. The Centre, established in 1999, is funded directly by NHS Specialised Services to provide diagnostic and management advisory services for all UK amyloidosis patients.Gift Aid supports the Royal Free Charity's full range of vital support services for staff and patients across the Royal Free London NHS Foundation Trust, as well as supporting research and innovation.